Zealand Pharma A/S (CPSE:ZEAL) commences share repurchases on May 7, 2026, under the program mandated by the shareholders in the Annual General Meeting held on March 26, 2026. As per the mandate, the company is authorized to repurchase its own shares. The company's aggregated repurchase of shares shall not exceed a total nominal value of 10% of its share capital at any given time.
The repurchase price for the shares may not deviate by more than 10% from the quoted price for the company?s shares on Nasdaq Copenhagen at the time of purchase. The authorization will be valid until the next Annual General Meeting.
